Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation

The aims of this study are to 1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO). 2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO. 3. Evaluate the predictors for neoaortic valve regurgitation after ASO. 4. Explore the risk factors for neopulmonary artery stenosis after ASO.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Xie MingxingUpdated: Jul 13, 2022
Eligibility criteria

Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire... [+5]

Status: Not yet recruiting

A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Diabetes

The aims of this study are to 1. Evaluate the right heart structure and function in T2DM and Prediabetes patients by speckle tracking echocardiography, and to further investigate the influence of left heart on right heart structure and function in T2DM and Prediabetes patients. 2. To explore the prognostic value of right ventricular function in T2DM patients.

Participants needed: 2,300
Trial details
Age: 35-79Biological sex: AllType: ObservationalSponsor: Xie MingxingUpdated: Jul 13, 2022
Eligibility criteria

Not listed

Status: Not yet recruiting

Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation

The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.

Participants needed: 1,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Xie MingxingUpdated: Jul 19, 2021Duration: 10 Years
Eligibility criteria

Not listed